These mechanisms have been shown to be important in promoting hepatic diseases such as non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH), where LPS- and TLR4-associated inflammation plays a significant role (107). The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.